Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Where Do Plasma Biomarkers fit in With Current Alzheimer's Disease Detection?
Gildengers A, Weinstein AM, Gujral S, Zeng X, Diaz JL, Lafferty TK, Cowie M, Emanuel JE, Lopez O, Royse SK, Lopresti B, Karikari TK. Gildengers A, et al. Among authors: lafferty tk. Am J Geriatr Psychiatry. 2024 Oct 1:S1064-7481(24)00478-0. doi: 10.1016/j.jagp.2024.09.015. Online ahead of print. Am J Geriatr Psychiatry. 2024. PMID: 39448295 Free article.
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.
Zeng X, Lafferty TK, Sehrawat A, Chen Y, Ferreira PCL, Bellaver B, Povala G, Kamboh MI, Klunk WE, Cohen AD, Lopez OL, Ikonomovic MD, Pascoal TA, Ganguli M, Villemagne VL, Snitz BE, Karikari TK. Zeng X, et al. Among authors: lafferty tk. Mol Neurodegener. 2024 Oct 10;19(1):68. doi: 10.1186/s13024-024-00753-5. Mol Neurodegener. 2024. PMID: 39385222 Free PMC article.
A streamlined, resource-efficient immunoprecipitation-mass spectrometry method for quantifying plasma amyloid-β biomarkers in Alzheimer's disease.
Karikari T, Chen Y, Zeng X, Olvera-Rojas M, Sehrawat A, Lafferty T, Pascoal T, Villemagne V, Solis-Urra P, Triviño-Ibañez E, Gómez-Rí M, Cohen A, Ikonomovic M, Esteban-Cornejo I, Erickson K, Lopez O, Yates N. Karikari T, et al. Among authors: lafferty t. Res Sq [Preprint]. 2024 Sep 2:rs.3.rs-4947448. doi: 10.21203/rs.3.rs-4947448/v1. Res Sq. 2024. PMID: 39281858 Free PMC article. Preprint.
Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease.
Zeng X, Lafferty TK, Sehrawat A, Chen Y, Ferreira PCL, Bellaver B, Povala G, Kamboh MI, Klunk WE, Cohen AD, Lopez OL, Ikonomovic MD, Pascoal TA, Ganguli M, Villemagne VL, Snitz BE, Karikari TK. Zeng X, et al. Among authors: lafferty tk. medRxiv [Preprint]. 2024 Jun 16:2024.06.15.24308975. doi: 10.1101/2024.06.15.24308975. medRxiv. 2024. Update in: Mol Neurodegener. 2024 Oct 10;19(1):68. doi: 10.1186/s13024-024-00753-5 PMID: 38947065 Free PMC article. Updated. Preprint.
Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting.
Zeng X, Chen Y, Sehrawat A, Lee J, Lafferty TK, Kofler J, Berman SB, Sweet RA, Tudorascu DL, Klunk WE, Ikonomovic MD, Pfister A, Zetterberg H, Snitz BE, Cohen AD, Villemagne VL, Pascoal TA, Kamboh MI, Lopez OI, Blennow K, Karikari TK. Zeng X, et al. Among authors: lafferty tk. Mol Neurodegener. 2024 May 15;19(1):40. doi: 10.1186/s13024-024-00711-1. Mol Neurodegener. 2024. PMID: 38750570 Free PMC article. Review.
Effect of blood collection tube containing protease inhibitors on the pre-analytical stability of Alzheimer's disease plasma biomarkers.
Chen Y, Zeng X, Lee J, Sehrawat A, Lafferty TK, Boslett JJ, Klunk WE, Pascoal TA, Villemagne VL, Cohen AD, Lopez O, Yates NA, Karikari TK. Chen Y, et al. Among authors: lafferty tk. medRxiv [Preprint]. 2024 Mar 7:2024.03.05.24303504. doi: 10.1101/2024.03.05.24303504. medRxiv. 2024. Update in: J Neurochem. 2024 Sep;168(9):2736-2750. doi: 10.1111/jnc.16130 PMID: 38496591 Free PMC article. Updated. Preprint.
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
Bowman P, Sulen Å, Barbetti F, Beltrand J, Svalastoga P, Codner E, Tessmann EH, Juliusson PB, Skrivarhaug T, Pearson ER, Flanagan SE, Babiker T, Thomas NJ, Shepherd MH, Ellard S, Klimes I, Szopa M, Polak M, Iafusco D, Hattersley AT, Njølstad PR; Neonatal Diabetes International Collaborative Group. Bowman P, et al. Lancet Diabetes Endocrinol. 2018 Aug;6(8):637-646. doi: 10.1016/S2213-8587(18)30106-2. Epub 2018 Jun 4. Lancet Diabetes Endocrinol. 2018. PMID: 29880308 Free PMC article.
20 results